-
1
-
-
0037425743
-
Gut flora in health and disease
-
See comment
-
Guarner F, Malagelada JR. Gut flora in health and disease. [See comment]. Lancet, 2003;361(9356):512-519.
-
(2003)
Lancet
, vol.361
, Issue.9356
, pp. 512-519
-
-
Guarner, F.1
Malagelada, J.R.2
-
2
-
-
2442453484
-
Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics
-
Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology, 2004;126(6):1620-1633.
-
(2004)
Gastroenterology
, vol.126
, Issue.6
, pp. 1620-1633
-
-
Sartor, R.B.1
-
5
-
-
0029586031
-
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
-
Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448-455.
-
(1995)
Clin Exp Immunol
, vol.102
, pp. 448-455
-
-
Duchmann, R.1
Kaiser, I.2
Hermann, E.3
-
6
-
-
0029866466
-
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria
-
MacPherson A, Khoo UY, Forgacs I, et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut, 1996;38:365-375.
-
(1996)
Gut
, vol.38
, pp. 365-375
-
-
MacPherson, A.1
Khoo, U.Y.2
Forgacs, I.3
-
7
-
-
2442524857
-
Microbial influences in inflammatory bowel disease: Role in pathogenesis and clinical implications
-
Sartor RB and Sandborn WJ, eds. Edinburgh: Elsevier
-
Sartor RB. Microbial influences in inflammatory bowel disease: role in pathogenesis and clinical implications. In: Sartor RB and Sandborn WJ, eds. Kirsner's Inflammatory Bowel Diseases. 6th ed. Edinburgh: Elsevier; 2003:138-162.
-
(2003)
Kirsner's Inflammatory Bowel Diseases. 6th Ed.
, pp. 138-162
-
-
Sartor, R.B.1
-
8
-
-
0036117798
-
Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease
-
Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol, 2002;97:939-946.
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 939-946
-
-
Neut, C.1
Bulois, P.2
Desreumaux, P.3
-
10
-
-
0027563343
-
An immunocytochemical search for infectious agents in Crohn's disease
-
Cartun RW, Van Kruiningen HJ, Pedersen CA, et al. An immunocytochemical search for infectious agents in Crohn's disease. Mod Path, 1993;6:212-219.
-
(1993)
Mod Path
, vol.6
, pp. 212-219
-
-
Cartun, R.W.1
Van Kruiningen, H.J.2
Pedersen, C.A.3
-
11
-
-
0034183435
-
Probiotics and inflammatory bowel disease: Is there a scientific rationale?
-
Shanahan F. Probiotics and inflammatory bowel disease: Is there a scientific rationale? Inflamm Bowel Dis, 2000;6:107-115.
-
(2000)
Inflamm Bowel Dis
, vol.6
, pp. 107-115
-
-
Shanahan, F.1
-
12
-
-
0031915148
-
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
-
D'Haens G, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology, 1998;114:262-267.
-
(1998)
Gastroenterology
, vol.114
, pp. 262-267
-
-
D'Haens, G.1
Geboes, K.2
Peeters, M.3
-
13
-
-
20244388832
-
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: A randomized, double-blind, placebo-controlled trial
-
Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology, 2005;128(4):856-861.
-
(2005)
Gastroenterology
, vol.128
, Issue.4
, pp. 856-861
-
-
Rutgeerts, P.1
Van Assche, G.2
Vermeire, S.3
-
14
-
-
2542574746
-
Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation
-
Buning C, Genschel S, Buhner S, et al. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther, 2004;19:1073-1078.
-
(2004)
Aliment Pharmacol Ther
, vol.19
, pp. 1073-1078
-
-
Buning, C.1
Genschel, S.2
Buhner, S.3
-
15
-
-
0036716855
-
Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: A randomized controlled trial with Lactobacillus GG
-
Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomized controlled trial with Lactobacillus GG. Gut, 2002;51:405-409.
-
(2002)
Gut
, vol.51
, pp. 405-409
-
-
Prantera, C.1
Scribano, M.L.2
Falasco, G.3
-
16
-
-
0031443860
-
Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?
-
Malchow H. Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol, 1997;25(4):653-658.
-
(1997)
J Clin Gastroenterol
, vol.25
, Issue.4
, pp. 653-658
-
-
Malchow, H.1
-
17
-
-
0033870413
-
Saccharomyces boulardii in maintenance treatment of Crohn's disease
-
Guslandi M, Mezzi G, Sorghi M, et al. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci, 2000;45(7):1462-1464.
-
(2000)
Dig Dis Sci
, vol.45
, Issue.7
, pp. 1462-1464
-
-
Guslandi, M.1
Mezzi, G.2
Sorghi, M.3
-
18
-
-
0032815979
-
Inpact on the composition of the fecal flora by a new probiotic preparation: Preliminary data on the maintenance treatment of patients with ulcerative colitis
-
Venturi A, Gionchetti P, Rizzello F, et al. Inpact on the composition of the fecal flora by a new probiotic preparation: preliminary data on the maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther, 1999;13:1103-1108.
-
(1999)
Aliment Pharmacol Ther
, vol.13
, pp. 1103-1108
-
-
Venturi, A.1
Gionchetti, P.2
Rizzello, F.3
-
19
-
-
0033592203
-
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomized trial
-
Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomized trial. Lancet, 1999;354:635-639.
-
(1999)
Lancet
, vol.354
, pp. 635-639
-
-
Rembacken, B.J.1
Snelling, A.M.2
Hawkey, P.M.3
-
20
-
-
0000226162
-
Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine
-
Kruis W, Kalk EK, Fric P, et al. Maintenance of remission in ulcerative colitis is equally effective with Escherichia coli Nissle 1917 and with standard mesalamine (abstr). Gastroenterology, 2001;120:A127.
-
(2001)
Gastroenterology
, vol.120
-
-
Kruis, W.1
Kalk, E.K.2
Fric, P.3
-
21
-
-
0023521441
-
Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis - A randomized study
-
Schroeder K, Tremaine W, Sandborn W, Ilstrup D. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis-a randomized study. N Eng J Med, 1987;317:1625-1629.
-
(1987)
N Eng J Med
, vol.317
, pp. 1625-1629
-
-
Schroeder, K.1
Tremaine, W.2
Sandborn, W.3
Ilstrup, D.4
-
22
-
-
75549096111
-
Variation in observers in describing mucosal appearances in proctocolitis
-
Baron J, Connell A, Lennard-Jones J. Variation in observers in describing mucosal appearances in proctocolitis. BMJ 1964;i:89-92.
-
(1964)
BMJ
, vol.1
, pp. 89-92
-
-
Baron, J.1
Connell, A.2
Lennard-Jones, J.3
-
23
-
-
0038063405
-
VSL3 probiotic mixture induces remission in patients with active ulcerative colitis
-
Fedorak RN, Gionchetti P, Campieri M, et al. VSL3 probiotic mixture induces remission in patients with active ulcerative colitis (abstr). Gastroenterology, 2003;124:A377.
-
(2003)
Gastroenterology
, vol.124
-
-
Fedorak, R.N.1
Gionchetti, P.2
Campieri, M.3
-
25
-
-
0033860601
-
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
-
Gionchetti P, Rizzelo F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology, 2000;119:305-309.
-
(2000)
Gastroenterology
, vol.119
, pp. 305-309
-
-
Gionchetti, P.1
Rizzelo, F.2
Venturi, A.3
-
26
-
-
0001284907
-
Once daily high dose probiotic therapy maintains remission and improved quality of life in patients with recurrent or refractory pouchitis: A randomized, placebo-controlled, double-blind trial
-
Mimura T, Rizzello F, Schreiber S, et al. Once daily high dose probiotic therapy maintains remission and improved quality of life in patients with recurrent or refractory pouchitis: a randomized, placebo-controlled, double-blind trial (abst). Gastroenterology, 2002;122:A81.
-
(2002)
Gastroenterology
, vol.122
-
-
Mimura, T.1
Rizzello, F.2
Schreiber, S.3
-
27
-
-
0028345875
-
Pouchitis after ileal pouch-anal anastamosis: A pouchitis disease activity index
-
Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastamosis: a pouchitis disease activity index. Mayo Clinic Proc, 1994;69:409-415.
-
(1994)
Mayo Clinic Proc
, vol.69
, pp. 409-415
-
-
Sandborn, W.J.1
Tremaine, W.J.2
Batts, K.P.3
-
28
-
-
0038185270
-
Prophylaxis of pouchitis onset with probiotic therapy: A double-blind placebo controlled trial
-
Gionchetti P, Rizzelo F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind placebo controlled trial. Gastroenterology, 2003;124:1202-1209.
-
(2003)
Gastroenterology
, vol.124
, pp. 1202-1209
-
-
Gionchetti, P.1
Rizzelo, F.2
Helwig, U.3
-
29
-
-
33645777914
-
An open-labeled trial of probiotic as a maintenance therapy in patients with antibiotic-dependent pouchitis
-
Shen B, Fazio V, Remzi F, et al. An open-labeled trial of probiotic as a maintenance therapy in patients with antibiotic-dependent pouchitis. Gastroenterology, 2005;124:A586.
-
(2005)
Gastroenterology
, vol.124
-
-
Shen, B.1
Fazio, V.2
Remzi, F.3
-
30
-
-
0035055766
-
Long-term follow-up after ileoanal pouch procedure: Algorithm for diagnosis, classification and management of pouchitis
-
Heuschen UA, Autschbach F, Allemeyer EH, et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification and management of pouchitis. Dis Colon Rectum, 2001;44:487-499.
-
(2001)
Dis Colon Rectum
, vol.44
, pp. 487-499
-
-
Heuschen, U.A.1
Autschbach, F.2
Allemeyer, E.H.3
-
31
-
-
0034898590
-
Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis
-
Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology, 2001;121:261-267.
-
(2001)
Gastroenterology
, vol.121
, pp. 261-267
-
-
Shen, B.1
Achkar, J.P.2
Lashner, B.A.3
-
32
-
-
0346960119
-
Probiotics in inflammatory bowel disease: A critical review
-
Tamboli CP, Caucheteux C, Cortot A, Colombel JF, Desreumaux P. Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol, 2003;17(5):805-820.
-
(2003)
Best Pract Res Clin Gastroenterol
, vol.17
, Issue.5
, pp. 805-820
-
-
Tamboli, C.P.1
Caucheteux, C.2
Cortot, A.3
Colombel, J.F.4
Desreumaux, P.5
-
33
-
-
0002613273
-
Safety of probiotic bacteria
-
Salminen S, Von Wright A, eds. New York: Marcel Decker
-
Donohue DC, Salminen S, Marteau P. Safety of probiotic bacteria. In: Salminen S, Von Wright A, eds. Lactic Acid Bacteria. New York: Marcel Decker; 1998:369-384.
-
(1998)
Lactic Acid Bacteria
, pp. 369-384
-
-
Donohue, D.C.1
Salminen, S.2
Marteau, P.3
-
34
-
-
0034890663
-
Lactibacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis
-
Farina C, Arosio M, Mangia M, Moioli F. Lactibacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis. J Clin Gastroenterol, 2001;33:251-252.
-
(2001)
J Clin Gastroenterol
, vol.33
, pp. 251-252
-
-
Farina, C.1
Arosio, M.2
Mangia, M.3
Moioli, F.4
-
35
-
-
0029028825
-
Fungicemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea
-
Pletinex M, Legein J, Vandeplas Y. Fungicemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea. J Pediatr Gastroenterol Nutr, 1995;21:113-115.
-
(1995)
J Pediatr Gastroenterol Nutr
, vol.21
, pp. 113-115
-
-
Pletinex, M.1
Legein, J.2
Vandeplas, Y.3
-
36
-
-
2442495410
-
Probiotics and the management of inflammatory bowel disease
-
Fedorak RN, Madsen KL. Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis, 2004;10(3):286-299.
-
(2004)
Inflamm Bowel Dis
, vol.10
, Issue.3
, pp. 286-299
-
-
Fedorak, R.N.1
Madsen, K.L.2
-
37
-
-
0037215109
-
Saccharomyses cerevaciae fungemia after Saccharomyses boulardii treatment in immunocompromised patients
-
Riquelme AJ, Calvo MA, Guzman AM, et al. Saccharomyses cerevaciae fungemia after Saccharomyses boulardii treatment in immunocompromised patients. J Clin Gastroenterol, 2003;36(1):41-43.
-
(2003)
J Clin Gastroenterol
, vol.36
, Issue.1
, pp. 41-43
-
-
Riquelme, A.J.1
Calvo, M.A.2
Guzman, A.M.3
-
38
-
-
0032954103
-
Liver abcess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG
-
Rautio M, Jousimies-Somer H, Kauma H, et al. Liver abcess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis, 1999;28:1159-1160.
-
(1999)
Clin Infect Dis
, vol.28
, pp. 1159-1160
-
-
Rautio, M.1
Jousimies-Somer, H.2
Kauma, H.3
-
40
-
-
0033044663
-
Public health issues arising from microbiological and labelling quality foods and supplements containing probiotic organisms
-
Hamilton-Miller JMT, Shah S, Winkler JT. Public health issues arising from microbiological and labelling quality foods and supplements containing probiotic organisms. Public Health Nutr, 1999;2:223-229.
-
(1999)
Public Health Nutr
, vol.2
, pp. 223-229
-
-
Hamilton-Miller, J.M.T.1
Shah, S.2
Winkler, J.T.3
-
41
-
-
0037747750
-
Commercially available probiotic preparations: Are you getting what you pay for?
-
Katz JA, Pirovano F, Matteuzzi D, et al. Commercially available probiotic preparations: are you getting what you pay for? Gastroenterology, 2002;122(4):A459.
-
(2002)
Gastroenterology
, vol.122
, Issue.4
-
-
Katz, J.A.1
Pirovano, F.2
Matteuzzi, D.3
-
42
-
-
0034714188
-
Treatment of murine colitis by lactococcus lactis secreting interleukin-10
-
Steidler L, Hans W, Schotte L, et al. Treatment of murine colitis by lactococcus lactis secreting interleukin-10. Science, 2000;289:1352-1355.
-
(2000)
Science
, vol.289
, pp. 1352-1355
-
-
Steidler, L.1
Hans, W.2
Schotte, L.3
|